Marie P - Search Results

1

1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease.

Fournier AE, Bordier PJ, Gueris J, Chanard J, Marie P, Ferriere C, Osario M, Bedrossian J, De Luca HF. Fournier AE, et al. Among authors: marie p. Calcif Tissue Res. 1976 Aug;21 Suppl:226-35. Calcif Tissue Res. 1976. PMID: 782662 Clinical Trial. No abstract available.

2

1 alpha hydroxycholecalciferol and 25 hydroxycholecalciferol in renal bone disease.

Fournier AE, Bordier PJ, Gueris J, Chanard J, Marie P, Ferriere C, Osario M, Bedrossian J, de Luca HF. Fournier AE, et al. Among authors: marie p. Proc Eur Dial Transplant Assoc. 1976;12:227-36. Proc Eur Dial Transplant Assoc. 1976. PMID: 935115

3

Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.

Bordier PJ, Marie PJ, Arnaud CD. Bordier PJ, et al. Among authors: marie pj. Kidney Int Suppl. 1975 Jan;(2):102-12. Kidney Int Suppl. 1975. PMID: 1057669 No abstract available.

4

Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.

Fournier A, Bordier P, Gueris J, Sebert JL, Marie P, Ferrière C, Bedrossian J, DeLuca HF. Fournier A, et al. Among authors: marie p. Kidney Int. 1979 Feb;15(2):196-204. doi: 10.1038/ki.1979.25. Kidney Int. 1979. PMID: 513484 Free article. No abstract available.

5

The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.

Bordier P, Zingraff J, Gueris J, Jungers P, Marie P, Pechet M, Rasmussen H. Bordier P, et al. Among authors: marie p. Am J Med. 1978 Jan;64(1):101-7. doi: 10.1016/0002-9343(78)90184-5. Am J Med. 1978. PMID: 623125

6

Nonosteomalacic osteopathy associated with chronic hypophosphatemia.

de Vernejoul MC, Marie P, Kuntz D, Gueris J, Miravet L, Ryckewaert A. de Vernejoul MC, et al. Among authors: marie p. Calcif Tissue Int. 1982 May;34(3):219-23. doi: 10.1007/BF02411240. Calcif Tissue Int. 1982. PMID: 6809281

7

Vitamin D metabolites and bone mineralization in man.

Bordier P, Rasmussen H, Marie P, Miravet L, Gueris J, Ryckwaert A. Bordier P, et al. Among authors: marie p. J Clin Endocrinol Metab. 1978 Feb;46(2):284-94. doi: 10.1210/jcem-46-2-284. J Clin Endocrinol Metab. 1978. PMID: 750606

8

Effects of high dialysate calcium concentration on bone remodelling, serum biochemistry, and parathyroid hormone in patients with renal osteodystrophy.

Drüeke T, Bordier PJ, Man NK, Jungers P, Marie P. Drüeke T, et al. Among authors: marie p. Kidney Int. 1977 Apr;11(4):267-74. doi: 10.1038/ki.1977.40. Kidney Int. 1977. PMID: 857076 Free article.

9

[Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].

Sebert JL, Marie A, Kuntz D, Marie P, Gueris J, Smadja A, Fournier A, Quichaud J. Sebert JL, et al. Among authors: marie a, marie p. Rev Rhum Mal Osteoartic. 1981 Jul-Sep;48(7-9):535-41. Rev Rhum Mal Osteoartic. 1981. PMID: 7291931 French.

10

[Effect of vitamin D metabolites on mineralization of bone tissue and phosphocalcium metabolism disorders in the course of vitamin D deficiency osteomalacia].

Bordier P, Miravet L, Marie P, Guéris J, Rousselet F, Norman A, Rasmussen H, Ryckewaert A. Bordier P, et al. Among authors: marie p. Rev Rhum Mal Osteoartic. 1978 Apr;45(4):241-8. Rev Rhum Mal Osteoartic. 1978. PMID: 353964 Clinical Trial. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

605 results

Search Page

Filters